Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Johnson and Johnson
Medtronic
Moodys
Harvard Business School

Last Updated: September 26, 2022

Progenics Pharms Inc Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the competitive landscape for PROGENICS PHARMS INC, and when can generic versions of PROGENICS PHARMS INC drugs launch?

PROGENICS PHARMS INC has two approved drugs.

There are four US patents protecting PROGENICS PHARMS INC drugs.

There are sixty-three patent family members on PROGENICS PHARMS INC drugs in twenty-one countries.

Summary for Progenics Pharms Inc
International Patents:63
US Patents:4
Tradenames:2
Ingredients:2
NDAs:2

Drugs and US Patents for Progenics Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Progenics Pharms Inc PYLARIFY piflufolastat f-18 SOLUTION;INTRAVENOUS 214793-001 May 26, 2021 RX Yes Yes See Plans and Pricing See Plans and Pricing
Progenics Pharms Inc PYLARIFY piflufolastat f-18 SOLUTION;INTRAVENOUS 214793-001 May 26, 2021 RX Yes Yes 8,487,129 See Plans and Pricing Y Y See Plans and Pricing
Progenics Pharms Inc AZEDRA iobenguane i-131 SOLUTION;INTRAVENOUS 209607-001 Jul 30, 2018 RX Yes Yes See Plans and Pricing See Plans and Pricing
Progenics Pharms Inc PYLARIFY piflufolastat f-18 SOLUTION;INTRAVENOUS 214793-001 May 26, 2021 RX Yes Yes 9,861,713 See Plans and Pricing Y Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Merck
Express Scripts
Moodys
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.